Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Abbott To Focus On Higher-Margin Drug Products, Spins Off Hospital Division

Executive Summary

Abbott plans to focus investments on higher-margin products following the spin-off of its hospital products division

You may also be interested in...



Abbott Sets Hospira Spin-Off For May 3; Market Cap Estimated At $5 Bil.

Abbott Labs will complete the spin-off of its hospital products business Hospira on May 3

Abbott Sets Hospira Spin-Off For May 3; Market Cap Estimated At $5 Bil.

Abbott Labs will complete the spin-off of its hospital products business Hospira on May 3

Abbott hospital product spin-off named “Hospira”

Abbott's hospital products company will be named "Hospira" when it spins off in 2004. The name, suggested by an Abbott employee, edged out "Acubiq" in a vote by all Hospira employees. "Hospira is derived from the words hospital, spirit, inspire and the Latin word spero, which means hope," Abbott said. Abbott announced the spin-off of the division Aug. 22 (1"The Pink Sheet" Aug. 25, 2003, p. 13)...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS042340

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel